PARSIPPANY, N.J. / Sep 07, 2023 / Business Wire / Today, the Zoetis Foundation announced that it will distribute $2.6 million during its second round of 2023 grants, supporting six initiatives to help enable thriving professions and livelihoods for livestock farmers and veterinary professionals.
The Zoetis Foundation has selected grantees that will help provide greater access to education and mental wellness resources, provide veterinary education debt relief funding, support diversity and inclusion efforts, and help enable thriving livelihoods by funding programs that support veterinary practices and farmers adopting sustainable and resilient business practices. This year, the Foundation is proud to expand its support of veterinary mental health and wellness to Australia and the United Kingdom.
“From increasing educational access for the next generation of veterinary professionals and supporting well-being of current veterinarians to championing sustainable livestock farming, it’s critical that we support those who care for the animals we depend on,” said Jeannette Ferran Astorga, President of the Zoetis Foundation and Executive Vice President, Corporate Affairs, Communications and Sustainability at Zoetis. “In the second round of 2023 funding, we are pleased to continue building upon the success of the Foundation’s grantmaking thus far and expanding our funding to include new organizations, underscoring our commitment to advance opportunities for veterinarians and livestock farmers.”
The full list of second round 2023 grant recipients and expansion of programmatic work includes:
Education
Well-being
Livelihoods
Additionally, the Zoetis Foundation provided a second year of funding to Zoetis Colleague Resource Group (CRG) Philanthropy Grants Program, in alignment with the Foundation’s goal to prioritize diversity, equity, and inclusion across its focus areas. The CRG Philanthropy Grants Program invites Zoetis’ CRGs to propose grantee suggestions to the Zoetis Foundation for possible funding. This year’s program will benefit the Pets for the Elderly Foundation, the Asian Mental Health Collective, Management Leadership for Tomorrow, the Special Olympics, El Futuro, Inc., True Colors United, the Malala Fund and the National 4-H Council.
The Zoetis Foundation was announced in 2021 to support communities and the people who care for animals. From 2021-2022, the Foundation distributed $6.6 million to advance opportunities for veterinary professionals and farmers, support the matching gifts program, and provide relief to those impacted by the war in the Ukraine. So far in 2023, the Zoetis Foundation has approved approximately $8.1 million to advance farmer and veterinarian education, well-being and livelihoods, to support the matching gifts program, and to provide critical support to the communities impacted by the earthquake in Türkiye. The Zoetis Foundation is committed to its goal of $35 million in grants distributed by the end of 2025 to support the Foundation’s grantmaking priorities, with over one third of grant funding awarded thus far.
The Zoetis Foundation is not soliciting grant proposals at this time. The Zoetis Foundation is a private charitable organization and is solely funded by Zoetis Inc., with distinct legal requirements and restrictions.
About the Zoetis Foundation
The Zoetis Foundation supports communities and the people who care for animals, with a specific focus on advancing opportunities for veterinarians and farmers around the world. The Foundation’s grantmaking and strategic efforts provide access to education and mental wellness resources, expand veterinary debt relief, support diversity and inclusion efforts, and enable thriving livelihoods by funding programs that help veterinary practices and farmers adopt sustainable business practices. To learn more about the Foundation, please visit: www.zoetisfoundation.org.
Last Trade: | US$149.11 |
Daily Change: | 2.34 1.59 |
Daily Volume: | 810,206 |
Market Cap: | US$67.270B |
February 14, 2025 February 13, 2025 February 04, 2025 November 04, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load